NFE2L2 and ischemia: Recently, Nrf2/HO-1 activation has also been shown to have protective effects in aristolochic-acid-induced AKI55 and type 2 diabetic nephropathy29, as well as intestinal ischemia–reperfusion induced acute renal injury56.